West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 664.60 M

West Pharmaceutical Services, Inc. Operating Cash Flow is USD 664.60 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -12.16% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 756.60 M, a 6.43% change year over year.
  • West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 710.90 M, a 9.96% change year over year.
  • West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 646.50 M, a 28.25% change year over year.
  • West Pharmaceutical Services, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 504.10 M, a 33.82% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities